Skip to main content
. 2022 Jun 21;10:890882. doi: 10.3389/fbioe.2022.890882

FIGURE 6.

FIGURE 6

Epfn activation promotes ameloblast induction from mouse iPSCs partially by regulating the BMP-Smad pathway. (A) Diagram of ameloblast induction from Epfn-iPSCs. Dox (1 μg/ml) or 500 nM LDN-193189 (LDN, a BMP inhibitor) was added at stages 2 and 3 to activate Epfn expression or inhibit BMP-Smad signaling, respectively. (B) Western blotting on day 17. (C) Relative quantitative analysis of Western blot results. Different letters (e.g., A,B) indicate significant differences (p < 0.05; one-way ANOVA and Tukey’s test; n = 3). (D) ARS stain on day 17. Scale bar: 1 cm. (E) Quantification of ARS staining on day 17. Different letters (e.g., A,B) indicate significant differences (p < 0.05; one-way ANOVA and Tukey’s test; n = 3).